Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.

Int J Mol Med · 2018 · PMC6034915 · PMID 29717775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The inflammatory index showed a decreasing trend with time in the 10 μ M xanthatin treatment group, indicating that 10 μ M xanthatin effectively controlled the inflammatory response.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.